ClinVar Miner

Submissions for variant NM_000135.4(FANCA):c.2390C>T (p.Ala797Val)

gnomAD frequency: 0.00026  dbSNP: rs138248569
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000630849 SCV000751818 likely benign Fanconi anemia 2024-01-18 criteria provided, single submitter clinical testing
St. Jude Molecular Pathology, St. Jude Children's Research Hospital RCV000630849 SCV001737472 uncertain significance Fanconi anemia 2021-05-20 criteria provided, single submitter clinical testing The FANCA c.2390C>T (p.Ala797Val) missense change has a maximum frequency of 0.036% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/variant/16-89836359-G-A?dataset=gnomad_r2_1). In addition, the variant occurs in the homozygous state one time in gnomAD v2.1.1. Six of seven in silico tools predict a benign effect of this variant on protein function (BP4), but to our knowledge these predictions have not been confirmed by functional assays. The variant has been reported as heterozygous in one individual with head and neck carcinoma occurring before age 50 (PMID: 28678401). To our knowledge, this variant has not been reported in individuals with Fanconi anemia. In summary, this variant meets criteria to be classified as of uncertain significance based on the ACMG/AMP criteria: BP4.
Genetic Services Laboratory, University of Chicago RCV001821773 SCV002065244 uncertain significance not specified 2019-11-22 criteria provided, single submitter clinical testing
Sema4, Sema4 RCV000630849 SCV002534951 uncertain significance Fanconi anemia 2021-11-05 criteria provided, single submitter curation
GeneDx RCV002461940 SCV002757146 uncertain significance not provided 2022-05-24 criteria provided, single submitter clinical testing Reported in a patient with oropharynx carcinoma who also harbors an additional FANCA variant; however, detailed clinical information was not provided (Chandrasekharappa et al., 2017); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: Zahra2020[research], 28678401)
Natera, Inc. RCV001271599 SCV001452866 uncertain significance Fanconi anemia complementation group A 2020-09-16 no assertion criteria provided clinical testing
GenomeConnect - Invitae Patient Insights Network RCV001271599 SCV004037535 not provided Fanconi anemia complementation group A no assertion provided phenotyping only Variant classified as Uncertain significance and reported on 06-13-2019 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.